Piu’ Medical Più Medical Ammessa Alle Negoziazioni SU Euronext Growth Milan Stock: price and insider trades · Italy
Piu’ Medical Più Medical Ammessa Alle Negoziazioni SU Euronext Growth Milan: what insiders have been doing
Piu’ Medical Più Medical Ammessa Alle Negoziazioni SU Euronext Growth Milan has a thin disclosure history in our data (latest filing: 18 November 2025). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by Consob. They describe what insiders did and are not a recommendation.
Analyst consensus: bullish or bearish?
Analysts rate Piu’ Medical Più Medical Ammessa Alle Negoziazioni SU Euronext Growth Milan Strong Buy (bullish), based on 2 analysts. Average price target: €7.85.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended December 2024 · cache
- ●Executives0Consob
1 of 1 declaration
About Piu’ Medical Più Medical Ammessa Alle Negoziazioni SU Euronext Growth Milan
Piu’ Medical is a company operating in the healthcare and pharmaceutical sector, focused on developing innovative medical solutions. It is listed on Euronext Growth in Milan.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
